BIOR
Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
$0.22
+0.00% today
Updated 2026-04-30
Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$0 – $0
Volume
—
Biora Therapeutics Inc (BIOR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-65.13M | $-106.12M | $-165.74M | $-167.49M | $-64.42M | $-48.50M |
| Capital expenditures | $4.83M | $3.73M | $4.94M | $855000.00 | $792000.00 | $103000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $2.26M | $2.38M | $8.24M | $11.96M | $7.80M | $16.48M |
| Free cash flow | $-69.96M | $-109.85M | $-170.69M | $-168.34M | $-65.21M | $-48.60M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | $4.50M | $4.50M | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |